Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 1/2020

01-01-2020 | Endoscopy | Multicenter Seminars: IBD (MUSE: IBD)

Elevating the Technique: Resecting Complex Dysplastic Lesions of the Colon in Patients with Inflammatory Bowel Disease

Authors: Eshandeep S. Boparai, Fernando S. Velayos, Abhik Roy, Carolyn Li, Ahmed S. Alkoraishi, Craig A. Munroe

Published in: Digestive Diseases and Sciences | Issue 1/2020

Login to get access

Excerpt

A 50-year-old woman with no significant past medical history was referred for upper endoscopy and colonoscopy in order to investigate iron deficiency anemia. Laboratory values include a hemoglobin of 10.7 g/dL, mean corpuscular volume of 74 fL, iron level of 45 ug/dL, and ferritin < 5 ng/mL. She denied menorrhagia, diarrhea, melena, or overt rectal bleeding. …
Literature
1.
Velayos F, Kathpalia P, Finlayson E. Changing paradigms in detection of dysplasia and management of patients with inflammatory bowel disease: is colectomy still necessary? Gastroenterology. 2017;152:e1.CrossRef
2.
Blackstone MO, Riddell RH, Rogers BH, Levin B. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology. 1981;80:366–374.CrossRef
3.
Laine L, Kaltenbach T, Barkun A, et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastroenterology. 2015;148:e28.CrossRef
4.
Collins RH Jr, Feldman M, Fordtran JS. Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis. A critical review. N Engl J Med. 1987;316:1654–1658.CrossRef
5.
Buchner AM, Shahid MW, Heckman MG, et al. High-definition colonoscopy detects colorectal polyps at a higher rate than standard white-light colonoscopy. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2010;8:364–370.
6.
Rubin PH, Friedman S, Harpaz N, et al. Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps. Gastroenterology. 1999;117:1295–1300.CrossRef
7.
Engelsgjerd M, Farraye FA, Odze RD. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis. Gastroenterology. 1999;117:1288–1294. discussion 488-91.CrossRef
8.
Hurlstone DP, Sanders DS, Atkinson R, et al. Endoscopic mucosal resection for flat neoplasia in chronic ulcerative colitis: can we change the endoscopic management paradigm? Gut. 2007;56:838–846.CrossRef
9.
Iacopini F, Saito Y, Yamada M, et al. Curative endoscopic submucosal dissection of large nonpolypoid superficial neoplasms in ulcerative colitis (with videos). Gastrointest Endosc. 2015;82:734–738.CrossRef
10.
Suzuki N, Toyonaga T, East JE. Endoscopic submucosal dissection of colitis-related dysplasia. Endoscopy. 2017;49:1237–1242.CrossRef
11.
Kinoshita S, Uraoka T, Nishizawa T, et al. The role of colorectal endoscopic submucosal dissection in patients with ulcerative colitis. Gastrointest Endosc. 2018;87:1079–1084.CrossRef
12.
Kochhar G, Steele S, Sanaka M, Gorgun E. Endoscopic submucosal dissection for flat colonic polyps in patients with inflammatory bowel disease, a single-center experience. Inflamm Bowel Dis. 2018;24:e14–e15.CrossRef
13.
Gulati S, Emmanuel A, Burt M, Dubois P, Hayee B, Haji A. Outcomes of endoscopic resections of large laterally spreading colorectal lesions in inflammatory bowel disease: a single United Kingdom center experience. Inflamm Bowel Dis. 2018;24:1196–1203.CrossRef
14.
Yadav S, Loftus EV Jr, Harmsen WS, Wong Kee Song LM, Coelho-Prabhu N. Outcome of endoscopic resection of colonic polyps larger than 10 mm in patients with inflammatory bowel disease. Endosc Int Open. 2019;7:E994–E1001.CrossRef
15.
Yang DH, Kim J, Song EM, et al. Outcomes of ulcerative colitis-associated dysplasia patients referred for potential endoscopic submucosal dissection. J Gastroenterol Hepatol. 2019;34:1581–1589.CrossRef
16.
Repici A. From EMR to ESD: a new challenge from Japanese endoscopists. Dig Liver Dis. 2007;39:572–574.CrossRef
17.
Hong SN. Endoscopic therapeutic approach for dysplasia in inflammatory bowel disease. Clin Endosc. 2017;50:437–445.CrossRef
18.
Shen B, Kochhar G, Navaneethan U, et al. Role of interventional inflammatory bowel disease in the era of biologic therapy: a position statement from the Global Interventional IBD Group. Gastrointest Endosc. 2019;89:215–237.CrossRef
19.
Yang DH, Rey I. Endoscopic submucosal dissection for colitis-associated dysplasia. Clin Endosc. 2019;52:120–128.CrossRef
Metadata
Title
Elevating the Technique: Resecting Complex Dysplastic Lesions of the Colon in Patients with Inflammatory Bowel Disease
Authors
Eshandeep S. Boparai
Fernando S. Velayos
Abhik Roy
Carolyn Li
Ahmed S. Alkoraishi
Craig A. Munroe
Publication date
01-01-2020
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 1/2020
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-019-05931-w

Other articles of this Issue 1/2020

Digestive Diseases and Sciences 1/2020 Go to the issue

Original Article

Effect of TELEmedicine for Inflammatory Bowel Disease on Patient Activation and Self-Efficacy

Original Article

Geographical Disparities of Outcomes of Hepatocellular Carcinoma in France: The Heavier Burden of Alcohol Compared to Hepatitis C

Original Article

A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma

Invited Review

Bacterial Infection in Patients with Cirrhosis: Don’t Get Bugged to Death

Original Article

IRF-2 Inhibits Gastric Cancer Invasion and Migration by Down-Regulating MMP-1

Brief Report

Pocket-Sized Versus Conventional Ultrasound for Detecting Fatty Infiltration of the Liver
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits